News on Silico Research Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated Silico Research Limited news from BioPortfolio.com Wed, 10 Feb 2010 10:38:43 GMT en Three Questions Facing the Future of Compugenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039513&HITNO=0&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039513&THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039513&HITNO=0&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039513&THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Market Media: Software for drug optimizationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039138&HITNO=1&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039138&THISHREF=http://c.moreover.com/click/here.pl%3fz2537954081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039138&HITNO=1&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039138&THISHREF=http://c.moreover.com/click/here.pl%3fz2537954081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: First call for targets from MRC Centre for Therapeutics Discoveryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035196&HITNO=2&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035196&THISHREF=http://c.moreover.com/click/here.pl%3fz2536156074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035196&HITNO=2&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035196&THISHREF=http://c.moreover.com/click/here.pl%3fz2536156074%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Times: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036887&HITNO=3&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036887&HITNO=3&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036887&THISHREF=http://c.moreover.com/click/here.pl%3fz2536814320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036382&HITNO=4&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536592031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036382&HITNO=4&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036382&THISHREF=http://c.moreover.com/click/here.pl%3fz2536592031%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035239&HITNO=5&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035239&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035239&HITNO=5&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035239&THISHREF=http://c.moreover.com/click/here.pl%3fz2536163327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Compugen Ltd. Reports Fourth Quarter and Calendar 2009 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034944&HITNO=6&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034944&THISHREF=http://c.moreover.com/click/here.pl%3fz2536059661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034944&HITNO=6&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034944&THISHREF=http://c.moreover.com/click/here.pl%3fz2536059661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Fourth-quarter and full-year 2009 results announced by Compugenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034703&HITNO=7&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535935499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034703&HITNO=7&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034703&THISHREF=http://c.moreover.com/click/here.pl%3fz2535935499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Reports outline pharmaceuticals study results from University of Californiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026289&HITNO=8&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026289&THISHREF=http://c.moreover.com/click/here.pl%3fz2530592320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026289&HITNO=8&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026289&THISHREF=http://c.moreover.com/click/here.pl%3fz2530592320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPoten & Partners: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' inhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023401&HITNO=9&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023401&THISHREF=http://c.moreover.com/click/here.pl%3fz2528198594%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023401&HITNO=9&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023401&THISHREF=http://c.moreover.com/click/here.pl%3fz2528198594%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' inhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016298&HITNO=10&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016298&THISHREF=http://c.moreover.com/click/here.pl%3fz2524708796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016298&HITNO=10&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016298&THISHREF=http://c.moreover.com/click/here.pl%3fz2524708796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' in an Effort to Develop Drugs in Areas of Serious Unmet Needhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011640&HITNO=11&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011640&THISHREF=http://c.moreover.com/click/here.pl%3fz2523029240%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011640&HITNO=11&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011640&THISHREF=http://c.moreover.com/click/here.pl%3fz2523029240%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWashington Business Journal: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' in an Effort to Develop Drugs in Areas of Serious Unmet Needhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011351&HITNO=12&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011351&THISHREF=http://c.moreover.com/click/here.pl%3fz2522889102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011351&HITNO=12&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011351&THISHREF=http://c.moreover.com/click/here.pl%3fz2522889102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Jose Business Journal: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' inhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011124&HITNO=13&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011124&THISHREF=http://c.moreover.com/click/here.pl%3fz2522744356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011124&HITNO=13&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011124&THISHREF=http://c.moreover.com/click/here.pl%3fz2522744356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Medical Research Council Technology's Centre for Therapeutics Discovery Opens its First 'Call For Targets' in an Effort to Develop Drugs in Areas of Serious Unmet Needhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011068&HITNO=14&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011068&THISHREF=http://c.moreover.com/click/here.pl%3fz2522704963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011068&HITNO=14&MSIZE=96&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Silico%20Research%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011068&THISHREF=http://c.moreover.com/click/here.pl%3fz2522704963%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDallas Business Chronicle: